Quantbot Technologies LP Aerie Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$6.37 - $15.23 $7,784 - $18,611	1,222 New	1,222 $18,000
Q2 2022 Aug 09, 2022	SELL	$4.95 - $9.16 $11,424 - $21,141	-2,308 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $177,614 - $308,621	-31,492 Reduced 93.17%	2,308 $21,000
Q4 2021 Feb 11, 2022	BUY	$7.02 - $13.33 $237,276 - $450,554	33,800 New	33,800 $237,000
Q2 2021 Aug 12, 2021	SELL	$15.16 - $18.97 $50,755 - $63,511	-3,348 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $43,925 - $69,973	3,348 New	3,348 $59,000
Q4 2019 Feb 10, 2020	SELL	$17.72 - $25.1 $42,634 - $60,390	-2,406 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$18.41 - $28.0 $215,010 - $327,012	-11,679 Reduced 82.92%	2,406 $46,000
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $387,763 - $645,290	13,385 Added 1912.14%	14,085 $416,000
Q1 2019 May 13, 2019	BUY	$36.32 - $49.25 $25,424 - $34,475	700 New	700 $33,000
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $717 - $1,056	-15 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$51.15 - $61.0 $767 - $915	15 New	15 $0
Q4 2017 Feb 12, 2018	SELL	$50.85 - $65.1 $151,583 - $194,063	-2,981 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$48.6 - $60.1 $144,876 - $179,158	2,981	2,981 $144,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.